Nurse Practitioner in Crossett, AR Accepting Medicare

9 Nurse Practitioner nurses found. Showing 1 - 9

Karen Sowers Holman, APRN-CNP/FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 127 Dogwood Dr, Crossett, AR 71635 Phone: 870-364-3617

Mr. Charles L Smith, FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 909 Unity Rd, Crossett, AR 71635 Phone: 870-364-9111    Fax: 870-364-5581

Jenny Murphy, APRN Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 1015 Unity Rd, Crossett, AR 71635 Phone: 870-853-6116

Pamela S Winston, FNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 124 Ray Lochala Rd, Crossett, AR 71635 Phone: 870-364-0590

Cynthia E. Murphy, APRN Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 124 Ray Lochala Rd, Crossett, AR 71635 Phone: 870-364-0590    Fax: 870-305-4281

Julie Leanne Bays, APN Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 909 Unity Rd Ste B, Crossett, AR 71635 Phone: 870-364-9111    Fax: 870-364-1598

Cheryl Denise Rabalais, Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 124 Ray Lochala Rd, Crossett, AR 71635 Phone: 870-364-0590

Autumn Bennett, WHNP-BC Nurse Practitioner - Women's Health Medicare: Accepting Medicare Assignments Practice Location: 1003 Fred Lagrone Dr, Crossett, AR 71635 Phone: 870-364-3800

A Michele Maxwell, CNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 201 Fairview Rd Ste A, Crossett, AR 71635 Phone: 870-364-0000    Fax: 870-364-0199

News Archive

FDA advisory panels almost always recommend approval for new drugs and devices

Eleven randomly selected FDA advisory committees recommended approval for 79% of prescription drugs and medical devices that they considered during a seven-year period, according to a study released on Monday by the National Research Center for Women & Families, Bloomberg/Houston Chronicle reports.

Lancet series revisits issue of global mental health four years after first examination

Four years after the Lancet "published a special series on global mental health, highlighting the gap in provision between rich countries and the rest of the world," the journal has published a new series, including an "editorial accompanying the series, welcoming the initiatives in global mental health in the past four years, but saying 'there is still a long way to go and many challenges to face,'" IRIN reports.

NaturalNano nanotubes improve targeting of circulating tumor cells: Study

NaturalNano, Inc. announced today that Dr. Michael King, a researcher at Cornell University, has published a new study demonstrating how NaturalNano nanotubes can improve targeting of circulating tumor cells (CTC's). These nanotubes, when added to the surface where cancer cells are attracted, enhance the natural rolling mechanism that Dr. King believes will allow them to be exposed to specific drugs or other therapeutic agents, or isolated for diagnostic and research purposes.

Drug Discovery and Development to focus on pharmaceutical trends

NanoViricides, Inc., announced today that the Company's CEO, Eugene Seymour, MD, MPH has been invited as a panelist at the 2nd Annual Livingston Healthcare Summit on September 24th, 2009 in New York City.

Zalicus second quarter revenue decreases to $1.8 million

Zalicus Inc. today reported financial results for the second quarter ended June 30, 2011.

Read more Medical News

› Verified 7 days ago